CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,406 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,569 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,141 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Operating Officer bought 16,053 shares at an average $3.09 ($49,659)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,753 shares (to pay taxes)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,077 shares (to pay taxes)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,191 shares (to pay taxes)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,812 shares (to pay taxes)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,999 shares (to pay taxes)
- 4 Option exercise Director acquired 2,859 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,083 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,155 shares (to pay taxes)
Page 7 of 13 · 247 filings